S Danese, M Klopocka, EJ Scherl, J Romatowski… - Clinical …, 2021 - Elsevier
Background & Aims An immune component of inflammatory bowel disease is up-regulated
tumor necrosis factor-like ligand 1A (TL1A). Anti-TL1A antibodies such as PF-06480605, a …